At the core of Prof. Dr. Mark De Ridder’s work is a commitment to excellence in radiotherapy and oncology. As Head of the Radiotherapy Department and Coordinator of the Oncology Care Program at UZ Brussel, he leads a multidisciplinary team that combines expertise, compassion, and innovation to redefine cancer treatment.
Our approach merges cutting-edge clinical care with strong research foundations, ensuring state-of-the-art, evidence-based therapies. With advanced technologies like markerless stereotactic body radiotherapy, we deliver highly precise treatments, minimizing side effects and optimizing outcomes.
Beyond care, our mission drives scientific discovery. Research focuses on improving radiotherapy techniques and understanding tumor biology to develop innovative strategies. Programs like the Spearhead Strategic Research Program highlight the societal benefits of our work, improving both medicine and patient quality of life.
By integrating clinical excellence with impactful research, we aim to set a global standard in radiotherapy-oncology, ensuring patients and families receive the best possible care at every stage of their journey.
